Skip to content

Powering EV research to realize earlier disease detection.

We're speeding up the fight against cancer and other diseases by putting our breakthrough technology in the hands of leading researchers.

Advanced Technology

Accelerating EV Research

Faster Time to Discovery


exokeryx-team-culture-004-1At EXOKĒRYX, our roadmap to transforming research for early disease detection combines principles from the semiconductor industry with breakthrough biotechnology.

EVs (extracellular vesicles) are crucial to cellular communication within our bodies and can be a key factor in early disease detection.

EXOKĒRYX is leveraging semiconductor technology to power best-in-class tools for isolation, characterization, and the analysis of extracellular vesicles. 

Our novel automated chip-based platform leverages EV dipole moments for isolation that yields high recovery and purity. Transistor technology enables multi-omic EV biomarker identification and quantification with greater sensitivity and specificity than other on-market methods. 

Our superior sensitivity will enable researchers to detect cancer and other serious diseases earlier than is possible with current technologies.

It’s time to usher in the new next generation technology.

The Roadmap to Earlier Disease Detection

Demeter EVPrep

Advanced EV Isolation

Launching 2024


Multi-omic Biomarker Profiling 

In Development

Early Disease Detection

Targeted Biomarker Panels